Drug Development Committee
ATAC’s Drug Development Committee (DDC) works with government, academia and the pharmaceutical industry to provide a community perspective into the development of new HIV drugs and the utilization of HIV therapies.
Andy Kaytes and Michael Dorosh
Kevin Fisher and Fred Schaich
DDC Representative to the Board of Directors
To become a DDC member, you must apply to ATAC and be accepted as an ATAC member. Please note: to apply for DDC membership, you will be asked to answer questions related to financial disclosure of any income received from the pharmaceutical industry. For more information about becoming a member, please click here.